Publisher Correction: LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition

Sarah Proteau; Imène Krossa; Chrystel Husser; Maxime Guéguinou; Federica Sella; Karine Bille; Marie Irondelle; Mélanie Dalmasso; Thibault Barouillet; Yann Cheli; Céline Pisibon; Nicole Arrighi; Sacha Nahon-Estève; Arnaud Martel; Lauris Gastaud; Sandra Lassalle; Olivier Mignen; Patrick Brest; Nathalie M Mazure; Frédéric Bost; Stéphanie Baillif; Solange Landreville; Simon Turcotte; Dan Hasson; Saul Carcamo; Christophe Vandier; Emily Bernstein; Laurent Yvan-Charvet; Mitchell P Levesque; Robert Ballotti; Corine Bertolotto; Thomas Strub

doi:10.1038/s44321-024-00114-1

Publisher Correction: LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition

EMBO Mol Med. 2024 Sep;16(9):2262-2267. doi: 10.1038/s44321-024-00114-1.

Authors

Sarah Proteau^{1

2}, Imène Krossa^#^{1

2}, Chrystel Husser^#^{1

2}, Maxime Guéguinou^{3

4}, Federica Sella⁵, Karine Bille^{1

2}, Marie Irondelle¹, Mélanie Dalmasso^{1

2}, Thibault Barouillet⁶, Yann Cheli^{1

2}, Céline Pisibon^{1

2}, Nicole Arrighi^{1

2}, Sacha Nahon-Estève^{1

7}, Arnaud Martel^{1

7}, Lauris Gastaud⁸, Sandra Lassalle^{1

9}, Olivier Mignen¹⁰, Patrick Brest^{1

11}, Nathalie M Mazure^{1

12}, Frédéric Bost^{1

12}, Stéphanie Baillif^{1

7}, Solange Landreville^{13

14

15

16}, Simon Turcotte^{17

18}, Dan Hasson^{19

20}, Saul Carcamo^{19

20}, Christophe Vandier^{3

4}, Emily Bernstein¹⁹, Laurent Yvan-Charvet^{1

6}, Mitchell P Levesque⁵, Robert Ballotti^{1

2}, Corine Bertolotto^{21

22}, Thomas Strub^{23

24}

Affiliations

¹ University Côte d'Azur, Nice, France.
² Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France.
³ University of Tours, Tours, France.
⁴ Inserm, N2C UMR 1069, Tours, France.
⁵ Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
⁶ Inserm, Hematometabolism and metainflammation, team 13, Mediterranean Centre for Molecular Medicine, Nice, France.
⁷ Centre Hospitalier Universitaire of Nice, Department of Ophthalmology, Nice, France.
⁸ Centre Antoine Lacassagne, Nice, France.
⁹ Laboratory of Clinical and Experimental Pathology, University Hospital of Nice, FHU OncoAge, Cote d'Azur University, Biobank BB-0033-00025, IRCAN team 4, OncoAge FHU, Nice, France.
¹⁰ LBAI, UMR1227, Univ Brest, Inserm, Brest, France.
¹¹ IRCAN team 4, Inserm, CNRS, FHU-oncoAge, IHU-RESPIRera, Nice, France.
¹² Inserm, Cancer, Metabolism and environment, team, Equipe labellisée Ligue 2022, Mediterranean Centre for Molecular Medicine, Nice, France.
¹³ Département d'ophtalmologie et d'ORL-CCF, Faculté de médecine, Université Laval, Quebec City, QC, Canada.
¹⁴ CUO-Recherche and Axe médecine régénératrice, Centre de recherche du CHU de Québec-Université Laval, Quebec City, QC, Canada.
¹⁵ Centre de recherche sur le cancer de l'Université Laval, Quebec City, QC, Canada.
¹⁶ Centre de recherche en organogénèse expérimentale de l'Université Laval/LOEX, Quebec City, QC, Canada.
¹⁷ Cancer Axis, Centre de recherche du Centre Hospitalier de l'Université de Montréal/Institut du cancer de Montréal, Montréal, QC, Canada.
¹⁸ Hepato-Pancreato-Biliary Surgery and Liver Transplantation Service, Centre hospitalier de l'Université de Montréal, Montréal, QC, Canada.
¹⁹ Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
²⁰ Tisch Cancer Institute Bioinformatics for Next Generation Sequencing (BiNGS) Facility, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
²¹ University Côte d'Azur, Nice, France. [email protected].
²² Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France. [email protected].
²³ University Côte d'Azur, Nice, France. [email protected].
²⁴ Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France. [email protected].

^# Contributed equally.

Abstract

Publication types

Published Erratum